Needle- Not sure about the $40-50 figure, but we could sure see $20-30. Wonder if they'll un-halt trading in U.S. or just let the pressure build for another day?
You're spot on about this deal shedding light on how under-valued Kazia is at the moment!
- Forums
- ASX - By Stock
- Ann: Kazia licenses paxalisib to Simcere in Greater China
Needle- Not sure about the $40-50 figure, but we could sure see...
-
- There are more pages in this discussion • 107 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add KZA (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
LU7
LITHIUM UNIVERSE LIMITED
Alex Hanly, CEO
Alex Hanly
CEO
SPONSORED BY The Market Online